No abstract available
MeSH terms
-
Child
-
DNA Mutational Analysis
-
ERG1 Potassium Channel
-
Electrocardiography
-
Ether-A-Go-Go Potassium Channels / genetics*
-
Follow-Up Studies
-
Gene Expression Regulation
-
Genetic Predisposition to Disease*
-
Genetic Variation
-
Humans
-
Long QT Syndrome / diagnosis
-
Long QT Syndrome / drug therapy
-
Long QT Syndrome / genetics*
-
Male
-
Mexiletine / therapeutic use
-
NAV1.5 Voltage-Gated Sodium Channel / genetics*
-
Pedigree
-
Polymorphism, Single Nucleotide
-
Potassium Channels, Voltage-Gated / genetics*
-
Risk Assessment
-
Seizures / diagnosis
-
Seizures / etiology
-
Severity of Illness Index
-
Treatment Outcome
Substances
-
ERG1 Potassium Channel
-
Ether-A-Go-Go Potassium Channels
-
KCNE1 protein, human
-
KCNH2 protein, human
-
NAV1.5 Voltage-Gated Sodium Channel
-
Potassium Channels, Voltage-Gated
-
SCN5A protein, human
-
Mexiletine